After a liver cancer diagnosis, the weeks ahead typically follow a predictable sequence: additional imaging and tests to determine how advanced the cancer is, assembly of a specialist team, and a treatment plan tailored to your specific situation. The process can feel overwhelming, but understanding each step removes some of the uncertainty. Here’s what to expect.
Staging Tests Come First
Your doctors already know cancer is present, but they need to determine its size, location, and whether it has spread. This staging process drives every treatment decision that follows. Most people undergo a combination of CT scans and MRI, often with a contrast dye injected into a vein. Images are typically captured at three different time points after the dye is injected (called triple-phase imaging) to get the clearest possible picture of abnormal areas in the liver.
A biopsy is not always necessary. In many cases, imaging alone is enough to confirm the diagnosis and stage. When a biopsy is needed, it’s usually done with a thin needle inserted through the skin into the liver, guided by ultrasound or CT. Some cases require a slightly wider needle to collect a larger tissue sample. Occasionally, doctors use laparoscopy, a small surgical procedure with a camera inserted through a tiny incision in the abdomen, to directly examine the liver and take samples.
How Staging Shapes Your Outlook
Liver cancer is unusual among cancers in that staging considers not just the tumor itself but also how well your liver is functioning overall. The most widely used system, the Barcelona Clinic Liver Cancer (BCLC) classification, assigns one of five stages based on tumor size and number, liver function, and your general physical ability:
- Very early (stage 0): A single tumor 2 cm or smaller, with well-preserved liver function.
- Early (stage A): A single tumor, or up to three tumors each 3 cm or smaller, with reasonably good liver function.
- Intermediate (stage B): Multiple tumors that haven’t invaded blood vessels or spread beyond the liver.
- Advanced (stage C): Cancer has grown into blood vessels or spread to other parts of the body.
- Terminal (stage D): Severe liver damage and significant decline in physical function.
Your BCLC stage matters because it directly determines which treatments are on the table. Stages 0 through B are generally eligible for potentially curative or tumor-targeting procedures. Stage C is typically treated with systemic therapy (medications that work throughout the body). Stage D focuses on comfort and quality of life.
Survival Rates by Stage
The most recent national data, covering patients diagnosed between 2015 and 2021, shows five-year relative survival rates that vary significantly by how far the cancer has spread at diagnosis. For localized liver cancer (confined to the liver), the five-year survival rate is 85.6%. When cancer has reached nearby lymph nodes or tissues (regional), it’s 79.6%. For distant-stage cancer that has spread to other organs, the rate drops to 46.6%.
These numbers reflect averages across all patients and all treatments during that period. Your individual outlook depends on tumor characteristics, liver function, overall health, and which treatments you receive. Treatments have also continued to improve, so outcomes for people diagnosed today may be better than what historical data shows.
Your Medical Team
Liver cancer treatment typically involves a multidisciplinary team rather than a single doctor. At most cancer centers, your case will be reviewed by a tumor board that includes a liver surgeon, a medical oncologist, an interventional radiologist (who performs minimally invasive procedures), a radiation oncologist, a hepatologist (liver specialist), a diagnostic radiologist who reads your scans, and a pathologist who examines tissue samples. This group meets to discuss your case collectively and agree on a recommended treatment plan. You won’t interact with all of them directly, but their input shapes your care.
Surgery: Resection and Transplant
For early-stage liver cancer, surgery offers the best chance at a cure, and it comes in two forms. Liver resection removes the portion of the liver containing the tumor. The remaining liver tissue regenerates over several weeks. This option works best when you have a single tumor and enough healthy liver tissue to sustain normal function after the surgery.
Liver transplantation replaces the entire diseased liver with a healthy donor organ. It’s generally considered for patients who meet specific size criteria: typically a single tumor no larger than 5 cm, or up to three tumors each 3 cm or smaller (known as the Milan criteria). A large analysis of over 18,000 patients found that transplant generally produces better long-term survival and significantly lower recurrence rates compared to resection for patients within these criteria. The trade-off is the wait for a donor organ, which can take months or longer depending on your region and blood type. During the wait, other treatments are often used to keep the cancer from progressing.
Tumor-Targeting Procedures
When surgery isn’t an option, or while waiting for a transplant, doctors often use procedures that target tumors directly without removing them. The two most common are radiofrequency ablation and chemoembolization, sometimes used together.
Radiofrequency ablation (RFA) uses a needle-like probe inserted through the skin and into the tumor. The probe delivers a high-frequency electrical current that generates heat, destroying cancer cells. Recovery is relatively quick, and most people go home within a day or two. About four weeks after the procedure, a follow-up CT scan checks whether the tumor was fully destroyed. If viable tumor tissue remains, an additional session can be performed.
Chemoembolization (TACE) works differently. A catheter is threaded through a blood vessel in the groin up to the artery supplying the tumor. Chemotherapy drugs are delivered directly to the tumor, then the artery is blocked with tiny particles, cutting off the tumor’s blood supply. This traps the drugs inside the tumor while starving it of oxygen and nutrients.
When the two are combined, chemoembolization is performed first, followed by ablation within about two weeks. Reducing blood flow to the tumor first makes ablation more effective by preventing blood from carrying heat away from the treatment zone. After treatment, follow-up imaging happens every three months for the first two years, then every six months through year five.
Immunotherapy and Systemic Treatment
For advanced liver cancer that has invaded blood vessels or spread beyond the liver, systemic therapy is the primary approach. The treatment landscape has shifted substantially toward immunotherapy. In April 2025, the FDA approved a combination of two immunotherapy drugs as a first-line treatment for adults with liver cancer that cannot be surgically removed or has spread. This combination achieved tumor shrinkage in 36% of patients, compared to 13% with the previous standard targeted therapies. Immunotherapy works by helping your immune system recognize and attack cancer cells that it would otherwise overlook.
Systemic treatment is given in cycles, with periods of treatment followed by rest periods. Side effects vary but can include fatigue, skin reactions, digestive issues, and inflammation in various organs. Your oncologist will monitor you closely with blood tests and imaging throughout treatment.
Managing Physical Symptoms
Liver cancer and its treatments can cause symptoms that need their own management, separate from cancer treatment itself.
Ascites, the buildup of fluid in the abdomen, is one of the most common. It causes bloating, discomfort, and sometimes difficulty breathing. Diuretics (water pills) are the standard first step, usually a combination of two types that work on different parts of the kidney. When fluid buildup is severe or doesn’t respond to medication, a procedure called paracentesis drains the fluid directly through a needle inserted into the abdomen. This provides quick relief, though the fluid often re-accumulates over time.
Jaundice, the yellowing of skin and eyes, happens when the tumor blocks bile ducts. It can cause intense itching that’s difficult to manage with regular anti-itch treatments. Doctors can relieve the blockage by placing a small tube (stent) in the bile duct or by inserting a drain through the skin. For the itching itself, a medication that binds bile acids in the gut can help. Simple measures also matter: fragrance-free soaps, regular use of moisturizers, and avoiding hot showers that dry out skin.
Nutrition After Diagnosis
Weight loss and muscle wasting are common in liver cancer, and they can directly affect how well you tolerate treatment. Current guidelines recommend that cancer patients consume significantly more protein than healthy adults: up to 1.5 grams per kilogram of body weight per day or more, compared to the standard 0.8 grams for healthy people. For a 150-pound person, that translates to roughly 100 grams of protein daily.
Nutritional screening should happen at diagnosis and be repeated throughout treatment. If you’ve lost significant weight, especially more than 15% of your body weight in the past three to six months, or have eaten very little for an extended period, restarting nutrition needs to happen gradually. Jumping straight to full meals after prolonged poor intake can cause dangerous shifts in electrolytes, a condition called refeeding syndrome. Your care team should monitor for this and increase your calorie intake slowly over several days.
Vitamin D deficiency is also common in cancer patients and may affect how well your body uses the protein you consume. Ask your team about checking your vitamin D levels.
Questions Worth Asking Your Doctor
The volume of information after a diagnosis can make it hard to know what to focus on during appointments. A few questions tend to be especially useful:
- Would a clinical trial be appropriate for me? Trials offer access to newer treatments and are available at various stages, not just as a last resort.
- Can you refer me to a palliative care specialist? Palliative care is not the same as hospice. It focuses on managing symptoms and side effects at any stage of treatment, alongside active cancer therapy.
- What are the realistic goals of treatment in my case? Whether the aim is cure, long-term control, or comfort changes the calculus of what you’re willing to go through.
- What symptoms should prompt me to call between appointments? Knowing your specific red flags reduces anxiety about every new sensation while ensuring you don’t ignore something that matters.